Michael W. Draper

2.1k total citations
34 papers, 1.6k citations indexed

About

Michael W. Draper is a scholar working on Genetics, Endocrinology, Diabetes and Metabolism and Orthopedics and Sports Medicine. According to data from OpenAlex, Michael W. Draper has authored 34 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Genetics, 16 papers in Endocrinology, Diabetes and Metabolism and 9 papers in Orthopedics and Sports Medicine. Recurrent topics in Michael W. Draper's work include Estrogen and related hormone effects (20 papers), Menopause: Health Impacts and Treatments (11 papers) and Bone health and osteoporosis research (9 papers). Michael W. Draper is often cited by papers focused on Estrogen and related hormone effects (20 papers), Menopause: Health Impacts and Treatments (11 papers) and Bone health and osteoporosis research (9 papers). Michael W. Draper collaborates with scholars based in United States, Belgium and Denmark. Michael W. Draper's co-authors include William J. Huster, Claude D. Arnaud, Kristine D. Harper, Axel G. Feller, Inge W. Rudman, Daniel Rudman, Lester Cohn, Robert P. Heaney, Wendy Shelly and Mayme Wong and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Michael W. Draper

32 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael W. Draper United States 18 856 661 429 406 395 34 1.6k
Helenius J. Kloosterboer United States 21 676 0.8× 596 0.9× 275 0.6× 29 0.1× 151 0.4× 42 1.3k
Carmen J. Narvaez United States 21 550 0.6× 157 0.2× 467 1.1× 77 0.2× 417 1.1× 29 1.6k
David R. Powell United States 27 237 0.3× 1.8k 2.8× 1.0k 2.3× 35 0.1× 145 0.4× 39 2.6k
Theo Pelzer Germany 23 479 0.6× 449 0.7× 363 0.8× 13 0.0× 422 1.1× 48 1.6k
G. Piscitelli Italy 16 660 0.8× 953 1.4× 167 0.4× 12 0.0× 440 1.1× 26 1.8k
Inna Astapova United States 19 284 0.3× 554 0.8× 674 1.6× 17 0.0× 84 0.2× 34 1.4k
Russell J. Wiese United States 14 324 0.4× 619 0.9× 1.2k 2.8× 20 0.0× 84 0.2× 26 2.0k
Rosa Di Paola Italy 21 282 0.3× 341 0.5× 682 1.6× 10 0.0× 104 0.3× 64 1.8k
Pamela Harding United States 28 86 0.1× 274 0.4× 698 1.6× 30 0.1× 202 0.5× 62 1.8k
Rongrong Cui China 25 112 0.1× 135 0.2× 885 2.1× 64 0.2× 226 0.6× 59 1.8k

Countries citing papers authored by Michael W. Draper

Since Specialization
Citations

This map shows the geographic impact of Michael W. Draper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael W. Draper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael W. Draper more than expected).

Fields of papers citing papers by Michael W. Draper

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael W. Draper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael W. Draper. The network helps show where Michael W. Draper may publish in the future.

Co-authorship network of co-authors of Michael W. Draper

This figure shows the co-authorship network connecting the top 25 collaborators of Michael W. Draper. A scholar is included among the top collaborators of Michael W. Draper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael W. Draper. Michael W. Draper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shelly, Wendy, Michael W. Draper, Venkatesh Krishnan, Mayme Wong, & Robert B. Jaffe. (2008). Selective Estrogen Receptor Modulators: An Update on Recent Clinical Findings. Obstetrical & Gynecological Survey. 63(3). 163–181. 147 indexed citations
2.
Draper, Michael W.. (2006). An update on raloxifene. International Journal of Gynecological Cancer. 16(s2). 502–503. 6 indexed citations
3.
Geiser, Andrew G., Conrad W. Hummel, Michael W. Draper, et al.. (2005). A New Selective Estrogen Receptor Modulator with Potent Uterine Antagonist Activity, Agonist Activity in Bone, and Minimal Ovarian Stimulation. Endocrinology. 146(10). 4524–4535. 42 indexed citations
4.
Reid, Ian R., Richard Eastell, Ignac Fogelman, et al.. (2004). A Comparison of the Effects of Raloxifene and Conjugated Equine Estrogen on Bone and Lipids in Healthy Postmenopausal Women. Archives of Internal Medicine. 164(8). 871–871. 53 indexed citations
5.
Draper, Michael W. & William W. Chin. (2003). Molecular and Clinical Evidence for the Unique Nature of Individual Selective Estrogen Receptor Modulators. Clinical Obstetrics & Gynecology. 46(2). 265–297. 4 indexed citations
6.
Draper, Michael W.. (2003). The Role of Selective Estrogen Receptor Modulators (SERMs) in Postmenopausal Health. Annals of the New York Academy of Sciences. 997(1). 373–377. 30 indexed citations
7.
Jolly, E., Nina H. Bjarnason, Patrick Neven, et al.. (2003). Prevention of osteoporosis and uterine effects in postmenopausal women taking raloxifene for 5 years. Menopause The Journal of The North American Menopause Society. 10(4). 337–344. 85 indexed citations
8.
Draper, Michael W.. (2002). SERMs: how do they work?. European Journal of Cancer. 38. 35–35. 3 indexed citations
9.
10.
Johnston, C. Conrad, Nina H. Bjarnason, Fredric J. Cohen, et al.. (2000). Long-term Effects of Raloxifene on Bone Mineral Density, Bone Turnover, and Serum Lipid Levels in Early Postmenopausal Women. Archives of Internal Medicine. 160(22). 3444–3444. 151 indexed citations
11.
Licata, Anna, et al.. (2000). Raloxifene: A new choice for treating and preventing osteoporosis. Cleveland Clinic Journal of Medicine. 67(4). 273–280. 5 indexed citations
12.
Meunier, P. J., Patrick Garnero, E. Paris, et al.. (1999). Treatment of Postmenopausal Women with Osteoporosis or Low Bone Density with Raloxifene. Osteoporosis International. 10(4). 330–336. 80 indexed citations
13.
Hol, T., et al.. (1997). Selective Estrogen Receptor Modulators and Postmenopausal Women's Health. PubMed. 6(5). 523–531. 43 indexed citations
14.
Heaney, Robert P. & Michael W. Draper. (1997). Raloxifene and Estrogen: Comparative Bone-Remodeling Kinetics1. The Journal of Clinical Endocrinology & Metabolism. 82(10). 3425–3429. 70 indexed citations
15.
Huster, William J., et al.. (1997). Effects of raloxifene hydrochloride on the endometrium of postmenopausal women. American Journal of Obstetrics and Gynecology. 177(6). 1458–1464. 115 indexed citations
16.
Chipman, John J., et al.. (1995). Approaching Final Height in Children Treated for Growth Hormone Deficiency. Hormone Research. 43(4). 129–131. 9 indexed citations
17.
Draper, Michael W., et al.. (1995). Antiestrogenic Properties of Raloxifene. Pharmacology. 50(4). 209–217. 34 indexed citations
18.
Fuchs‐Young, Robin, Lorri L. Short, Michael W. Draper, et al.. (1995). Raloxifene is a Tissue‐Selective Agonist/Antagonist That Functions through the Estrogen Receptor. Annals of the New York Academy of Sciences. 761(1). 355–360. 70 indexed citations
19.
Cohn, Lester, Axel G. Feller, Michael W. Draper, Inge W. Rudman, & Daniel Rudman. (1993). Carpal tunnel syndrome and gynaecomastia during growth hormone treatment of elderly men with low circulating IGF‐I concentrations. Clinical Endocrinology. 39(4). 417–425. 102 indexed citations
20.
Rudman, Daniel, Axel G. Feller, Lester Cohn, et al.. (1991). Effects of Human Growth Hormone on Body Composition in Elderly Men. Hormone Research. 36(1). 73–81. 126 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Helenius J. Kloosterboer Breakdown of academic impact, for papers by Carmen J. Narvaez Breakdown of academic impact, for papers by David R. Powell Breakdown of academic impact, for papers by Theo Pelzer Breakdown of academic impact, for papers by G. Piscitelli Breakdown of academic impact, for papers by Inna Astapova Breakdown of academic impact, for papers by Russell J. Wiese Breakdown of academic impact, for papers by Rosa Di Paola Breakdown of academic impact, for papers by Pamela Harding Breakdown of academic impact, for papers by Rongrong Cui
Rankless by CCL
2026